A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL ‐1401O vs. EU‐trastuzumab and US‐trastuzumab

British Journal of Clinical Pharmacology, EarlyView.

Source: British Journal of Clinical Pharmacology - August 1, 2018 Category: Drugs & Pharmacology Authors: Cornelius F.Waller , ApinyaVutikullird , Tracey E.Lawrence , AndrewShaw , Mark ShiyaoLiu , MarkBaczkowski , RajivSharma , AbhijitBarve , ParagGoyal , CharlesDonnelly , NilanjanSengupta , Eduardo J.Pennella Source Type: research